Loading clinical trials...
Loading clinical trials...
Pyruvate Kinase Deficiency Epidemiological Study. An International, Multicentre, Epidemiological Observational Study
Conditions
Locations
1
United States
Intervent Clinical Research Center
Pembroke Pines, Florida, United States
Start Date
January 13, 2020
Primary Completion Date
May 31, 2021
Completion Date
May 31, 2021
Last Updated
February 9, 2023
NCT05144256
NCT03481738
NCT02476916
NCT06422351
NCT04995315
NCT04964323
Lead Sponsor
CENTOGENE GmbH Rostock
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions